2. What Is HPV?
Human papillomavirus, or HPV, is a common group of viruses spread through close skin-to-skin contact, usually during sexual activity. Most HPV infections cause no problems and are cleared by the immune system.
Some high-risk HPV types can persist and cause cell changes that may develop into cancer over time. HPV is linked with cervical, anal, penile, vulval, vaginal and some mouth and throat cancers.
3. What the HPV Vaccine Does
The vaccine trains the immune system to recognise HPV types included in the vaccine. It works best before exposure, which is why the routine programme is offered in early adolescence.
4. HPV and Cancer Prevention
The UK currently uses Gardasil 9, which protects against nine HPV types. UKHSA guidance says the vaccine is highly effective at preventing infection with the included types and has reduced HPV-related disease in vaccinated groups.
It does not protect against every HPV type or every cancer. Vaccination is one part of prevention alongside cervical screening for eligible people, symptom awareness and appropriate medical assessment.
5. Who Is Offered HPV Vaccination in England?
Current NHS guidance says all children aged 12 to 13, usually in school year 8, are offered the vaccine through school or community services. Arrangements are available for children not attending school.
Eligibility and delivery differ across the UK and can change. This guide describes England; use the current NHS page or ask a vaccinating service for the position that applies to you.
6. Catch-Up and Higher-Risk Routes
Current NHS catch-up guidance offers free vaccination up to the 25th birthday to all eligible girls who missed it and to eligible boys born after 1 September 2006. Contact a school nurse, school vaccination team or GP surgery.
Gay, bisexual and other men who have sex with men can be vaccinated through sexual health or HIV clinics up to their 46th birthday. Vaccination is also sometimes recommended for other people at higher risk, including some trans people, sex workers and people with HIV. The service will confirm eligibility.
These are time-sensitive programme rules. Check current NHS eligibility (external link, opens in a new tab) rather than relying on an old invitation or age rule.
7. How the Vaccine Is Given
The vaccine is given into the upper arm. Current NHS guidance says eligible people under 25 usually have one dose; people aged 25 to 45 usually have two doses between 6 months and 2 years apart; and people with a weakened immune system have three doses over 12 months.
Individual schedules can differ. Follow the advice from the vaccinating service, including what to do if a dose was delayed.
8. Safety and Side Effects
The HPV vaccine has been used in the UK for many years. Common effects are usually mild and short-lived, such as pain or swelling at the injection site, headache, temperature, dizziness, nausea or tiredness.
A severe allergic reaction is very rare, and vaccinators are trained to respond. Tell the service about a previous serious allergic reaction, a high temperature, pregnancy or any concern. NHS guidance says the vaccine can be given while breastfeeding.
9. Limitations and Cervical Screening
- The vaccine does not treat an HPV infection, genital warts or existing cell changes.
- It does not protect against every HPV type or every HPV-related cancer.
- It does not prevent infections unrelated to HPV.
- Vaccinated people who are eligible for cervical screening should still attend when invited.
The HPV Test guide explains HPV results, while the NHS Cervical Screening guide explains the programme in England.
10. Common Myths
“The vaccine can give me HPV.”
No. It does not contain live HPV and cannot cause HPV infection.
“Vaccination treats an HPV-positive result.”
No. It prevents new infection; it does not clear an infection or treat cell changes already present.
“Vaccinated people do not need cervical screening.”
Incorrect. Eligible people should still attend because vaccination does not cover every cancer-causing HPV type.
11. Frequently Asked Questions
Who is routinely offered the HPV vaccine?
Can I catch up if I missed it at school?
How many doses are needed?
Can the vaccine treat an HPV infection I already have?
Is the HPV vaccine safe?
Do I still need cervical screening after vaccination?
Does the vaccine contain a live virus?
12. Evidence and References
Eligibility and dose schedules were checked against current NHS and UKHSA guidance for England in August 2026.
- HPV vaccine (external link, opens in a new tab)
Current NHS eligibility, catch-up routes, doses, safety and access information.
Source: NHS
- Human papillomavirus (HPV) (external link, opens in a new tab)
NHS information about HPV, transmission, prevention and cervical screening.
Source: NHS
- HPV vaccination guidance for healthcare practitioners (external link, opens in a new tab)
UKHSA programme guidance, schedules, eligibility and evidence for the current UK HPV vaccine.
Source: UK Health Security Agency and GOV.UK
- HPV: the Green Book, chapter 18a (external link, opens in a new tab)
Official UK immunisation guidance on HPV vaccination, contraindications and schedules.
Source: UK Health Security Agency and GOV.UK
13. Official NHS Resources
- HPV vaccine (external link, opens in a new tab)
Current NHS eligibility, catch-up routes, doses, safety and access information.
Source: NHS
- Human papillomavirus (HPV) (external link, opens in a new tab)
NHS information about HPV, transmission, prevention and cervical screening.
Source: NHS
- HPV vaccination guidance for healthcare practitioners (external link, opens in a new tab)
UKHSA programme guidance, schedules, eligibility and evidence for the current UK HPV vaccine.
Source: UK Health Security Agency and GOV.UK
- HPV: the Green Book, chapter 18a (external link, opens in a new tab)
Official UK immunisation guidance on HPV vaccination, contraindications and schedules.
Source: UK Health Security Agency and GOV.UK
14. How BloomShield Helps
Clear information is one part of equitable access. BloomShield’s connected programmes support understanding, practical access and navigation across screening and care pathways.
ScreenSmart Communities™
builds understanding, confidence and informed participation through trusted community engagement.
ScreenAccess™
identifies and helps address practical, social and service barriers to screening access.
ScreenConnect™
supports navigation, coordination and continuity across screening and care pathways.

